摘要
Abstract Programmed cell death (PCD) involving caspases (apoptosis) maintains homeostasis through the controlled destruction of old and abnormal cells without an inflammatory response. However, caspases are also involved in other types of PCD, such as pyroptosis and necroptosis, which protect the host from cellular stress and infectious pathogens and play a key role in the development of inflammation through the activation of proinflammatory cytokines. In pathological conditions, including infectious, oncological, and other diseases, apoptotic elements combine with pyroptotic and necroptotic cell death processes, triggering a combined type of death known as “PANoptosis” (Pyroptosis, Apoptosis, and Necroptosis). Panoptosis is accompanied by a lytic form of cell death and the release of cytokines (IL-1β, TNF-α, INF-γ, etc.) and molecular danger patterns (PAMPs, DAMPs), which trigger the body’s inflammatory response. The key biochemical platform of panoptosis is the panoptosome, which includes innate immune mediators such as the receptor molecules ZBP1, AIM2, RIPK1/3, TAK1, NLRP12, and NLRC5, as well as regulatory proteins (CASP-1, CASP-6, CASP-8, ASC, NLRP3), and destructive cellular effectors (CASP-3, CASP-7, GSDMD, GSDME, MLKL). Panoptosomes regulate cell death mechanisms, the intensity of inflammatory responses, and the molecular patterns of panoptotic biochemical pathways, influencing the formation of the immune response to infections and other pathological conditions. Molecular regulators of panoptosis serve as targets for the development of new, effective treatments for infectious, oncological, and degenerative pathologies.